These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17092429

  • 21. The treatment targets of asthma: from laboratory to clinic.
    Fang C, Corrigan CJ, Ying S.
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):119-28. PubMed ID: 18691142
    [Abstract] [Full Text] [Related]

  • 22. Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.
    Riccioni G, Bucciarelli T, Mancini B, Di Ilio E, Palumbo G, D'Orazio N.
    Clin Ter; 2007 Jun; 158(4):363-70. PubMed ID: 17953289
    [Abstract] [Full Text] [Related]

  • 23. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children.
    Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, Wikström ME, Goldblatt J, Sly PD, Hales BJ, Thomas WR, Laing IA, LeSouëf PN, Holt PG.
    J Immunol; 2009 Aug 15; 183(4):2793-800. PubMed ID: 19620293
    [Abstract] [Full Text] [Related]

  • 24. Can inhaled corticosteroids influence the natural history of asthma?
    Murray CS.
    Curr Opin Allergy Clin Immunol; 2008 Feb 15; 8(1):77-81. PubMed ID: 18188022
    [Abstract] [Full Text] [Related]

  • 25. Arginine homeostasis in allergic asthma.
    Maarsingh H, Zaagsma J, Meurs H.
    Eur J Pharmacol; 2008 May 13; 585(2-3):375-84. PubMed ID: 18410920
    [Abstract] [Full Text] [Related]

  • 26. Proteome analysis of chronically inflamed lungs in a mouse chronic asthma model.
    Wong WS, Zhao J.
    Int Arch Allergy Immunol; 2008 May 13; 147(3):179-89. PubMed ID: 18594147
    [Abstract] [Full Text] [Related]

  • 27. New insights into the pathophysiology of the small airways in asthma.
    Tulic MK, Hamid Q.
    Clin Chest Med; 2006 Mar 13; 27(1):41-52, vi. PubMed ID: 16543051
    [Abstract] [Full Text] [Related]

  • 28. Role of mast cells in airway remodeling.
    Okayama Y, Ra C, Saito H.
    Curr Opin Immunol; 2007 Dec 13; 19(6):687-93. PubMed ID: 17761410
    [Abstract] [Full Text] [Related]

  • 29. The role of neuro-immune cross-talk in the regulation of inflammation and remodelling in asthma.
    Veres TZ, Rochlitzer S, Braun A.
    Pharmacol Ther; 2009 May 13; 122(2):203-14. PubMed ID: 19292991
    [Abstract] [Full Text] [Related]

  • 30. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
    Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS, Kumar RK.
    Clin Exp Allergy; 2008 May 13; 38(5):847-56. PubMed ID: 18307529
    [Abstract] [Full Text] [Related]

  • 31. The definition and diagnosis of asthma.
    Hargreave FE, Nair P.
    Clin Exp Allergy; 2009 Nov 13; 39(11):1652-8. PubMed ID: 19622089
    [Abstract] [Full Text] [Related]

  • 32. Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
    Barnes PJ.
    Clin Exp Allergy; 2009 Aug 13; 39(8):1145-51. PubMed ID: 19538350
    [Abstract] [Full Text] [Related]

  • 33. Basement membrane thickening and clinical features of children with asthma.
    Kim ES, Kim SH, Kim KW, Park JW, Kim YS, Sohn MH, Kim KE.
    Allergy; 2007 Jun 13; 62(6):635-40. PubMed ID: 17508967
    [Abstract] [Full Text] [Related]

  • 34. Asthma therapy and airway remodeling.
    Mauad T, Bel EH, Sterk PJ.
    J Allergy Clin Immunol; 2007 Nov 13; 120(5):997-1009; quiz 1010-1. PubMed ID: 17681364
    [Abstract] [Full Text] [Related]

  • 35. Diagnosis and treatment of refractory asthma.
    Urso DL, Vincenzo D, Pignataro E, Acri P, Cucinotta G.
    Eur Rev Med Pharmacol Sci; 2008 Nov 13; 12(5):315-20. PubMed ID: 19024216
    [Abstract] [Full Text] [Related]

  • 36. Clues to asthma pathogenesis from microarray expression studies.
    Rolph MS, Sisavanh M, Liu SM, Mackay CR.
    Pharmacol Ther; 2006 Jan 13; 109(1-2):284-94. PubMed ID: 16203040
    [Abstract] [Full Text] [Related]

  • 37. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ, Lee KS, Kim SR, Min KH, Choe YH, Moon H, Chae HJ, Yoo WH, Lee YC.
    J Immunol; 2009 Sep 01; 183(5):3259-67. PubMed ID: 19641141
    [Abstract] [Full Text] [Related]

  • 38. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme.
    Sel S, Wegmann M, Dicke T, Sel S, Henke W, Yildirim AO, Renz H, Garn H.
    J Allergy Clin Immunol; 2008 Apr 01; 121(4):910-916.e5. PubMed ID: 18325571
    [Abstract] [Full Text] [Related]

  • 39. Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation.
    Bjermer L.
    J Allergy Clin Immunol; 2007 Dec 01; 120(6):1269-75. PubMed ID: 18073122
    [Abstract] [Full Text] [Related]

  • 40. Assessing the health effects and risks associated with children's inhalation exposures--asthma and allergy.
    Selgrade MK, Plopper CG, Gilmour MI, Conolly RB, Foos BS.
    J Toxicol Environ Health A; 2008 Dec 01; 71(3):196-207. PubMed ID: 18097945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.